A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the Hand

Completed · Phase 2

Conditions studied: Actinic Keratosis

In brief

The purpose of this study is to examine the safety and toleration of PEP005 Topical Gel, administered on an actinic keratosis (AK) treatment area on the top of a hand.

Key facts

Study ID

NCT00544297

Run by

Peplin

People needed

12

Starts

2007-10-01

Expected to finish

2008-01-01

Last updated by the study team

2015-04-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male patients at least 18 years of age.
• Post-menopausal female patients
• 4 to 8 clinically typical, visible and discrete AK lesions within an area on the dorsum of one hand.
• Written informed consent has been obtained.
• Agreement from the patient to allow photographs of the selected AK treatment area to be taken and used as part of the study data package.

Where it is running

• Skin Surgery Medical Group Inc — San Diego, California, United States
• Gwinnett Clinical Research Centre — Snellville, Georgia, United States
• Dermatology Clinical Research Centre of San Antonio — San Antonio, Texas, United States
• Dermatology Associates of Tyler — Tyler, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.